Anne B. Cropp

Chief Scientific Officer Early Access Care

Seminars

Wednesday 15th July 2026
When Access Creates Evidence: Real-World Data from Expanded Access Programs
11:30 am
  • Real-world evidence generated through EAPs that has informed regulatory decisionmaking, contributing to EMA scientific advice discussions and, in specific cases, resulted in FDA labeling indications and marketing authorizations
  • This session will focus on the types of approaches and real regulatory results
Anne B. Cropp, Chief Scientific Officer, Early Access Care